Oral care compositions and methods of use
This invention relates to oral care compositions comprising zinc phosphate, a first source of stannous (e.g., stannous fluoride); and a second source of stannous, wherein the second source of stannous comprises stannous pyrophosphate, as well as to methods of using and of making these compositions.
1. An oral care composition comprising:
a zinc source;
a first source of stannous, wherein the stannous comprises stannous fluoride;
a second source of stannous, wherein the second source of stannous comprises stannous pyrophosphate;
a citrate buffer system, wherein the buffer system comprises tri-sodium citrate and citric acid; and
a thickening agent selected from the group consisting of carboxyvinyl polymers, hydroxyethyl cellulose, sodium carboxymethyl cellulose, sodium carboxymethyl hydroxyethyl cellulose, and a combination of two or more thereof.
2. The oral care composition of claim 1 , wherein the zinc source comprises zinc phosphate.
3. The oral care composition of claim 2 , wherein the zinc phosphate is a preformed salt of zinc phosphate.
4. The oral care composition of claim 1 , wherein the amount of zinc phosphate is from 0.05 to 10 wt. %, relative to the total weight of the oral care composition.
5. The oral care composition of claim 1 further comprising one or more alkali phosphate salts.
6. The oral care composition of claim 5 , wherein the one or more alkali phosphate salts is selected from sodium phosphate dibasic, potassium phosphate dibasic, dicalcium phosphate dihydrate, calcium pyrophosphate, tetrasodium pyrophosphate, tetrapotassium pyrophosphate, sodium tripolyphosphate, disodium hydrogen orthophosphate, monosodium phosphate, pentapotassium triphosphate, and a mixture of two or more thereof.
7. The oral care composition of claim 5 , wherein the one or more alkali phosphate comprises sodium tripolyphosphate.
8. The oral care composition of claim 5 , wherein the stannous pyrophosphate is present in an amount from 0.1 to 3 wt. %, relative to the total weight of the oral care composition.
9. An oral care composition comprising:
a zinc source;
a first source of stannous, wherein the stannous comprises stannous fluoride;
a second source of stannous other than stannous fluoride; and
one or more surfactant, wherein the total amount of the one or more surfactant is from about 0.1 to 3 wt. %, based on the total weight of the oral care composition.
10. The oral care composition according to claim 9 , wherein the zinc source comprises zinc phosphate, zinc chloride, zinc lactate, zinc sulfate, or a mixture thereof.
11. The oral care composition of claim 9 , wherein the zinc source comprises zinc phosphate.
12. The oral care composition of claim 9 , wherein the amount of zinc phosphate is from 0.05 to 10 wt. %, relative to the total weight of the oral care composition.
13. The oral care composition according to claim 9 , wherein the second stannous source is selected from stannous chloride dihydrate, stannous pyrophosphate, organic stannous carboxylate salts, and a mixture of two or more thereof.
14. The oral care composition according to claim 9 , wherein the second stannous source is present in an amount from 0.1 to 3 wt. %, relative to the total weight of the oral care composition.
15. The oral care composition of claim 9 further comprising one or more alkali phosphate salts.
16. The oral care composition of claim 15 , wherein the one or more alkali phosphate salts is selected from sodium phosphate dibasic, potassium phosphate dibasic, dicalcium phosphate dihydrate, calcium pyrophosphate, tetrasodium pyrophosphate, tetrapotassium pyrophosphate, sodium tripolyphosphate, disodium hydrogen orthophosphate, monosodium phosphate, pentapotassium triphosphate, and a mixture of two or more thereof.
17. The oral care composition of claim 16 , wherein the one or more alkali phosphate comprises sodium tripolyphosphate.
18. The oral care composition of claim 9 further comprising a citrate buffer system, wherein the buffer system comprises tri-sodium citrate and citric acid.